Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Crypto Bank Silvergate Capital Winds Down Operations
Crypto bank Silvergate Capitalhas announced that it is winding down its operations and liquidating its assets.
Cheddar Morning News Briefings of March 9th
Cheddar Morning News Briefings
Morning Alexa Flash Briefings of March 9th
Morning Alexa Flash Briefings
Today Explained: The Pay Gap
Today Explained dives into a new report that explains how much the economy would improve if we can close the gender pay gap.
U.S. Judge: California Can't Ban Alligator Imports, Sales
California cannot ban the importation and sale of crocodile and alligator products, a federal judge has ruled, in a victory for the state of Louisiana, which challenged the ban along with businesses in multiple states.
What to Know About Student Loan Repayments
Jake Falcon, the founder of Falcon Wealth Advisors, joined Cheddar News to give some tips about student loan repayments.
Spotify Rolls Out Major App Redesign
Spotify Rolls Out Major App Redesign
Two Eyedrop Brands Recalled for Contamination
Two Eyedrop Brands Recalled for Contamination
U.S. Agency Opens Probe Into 120,000 Tesla Model Y Vehicles
U.S. Agency Opens Probe Into 120,000 Tesla Model Y Vehicles
